Literature DB >> 16436755

Streptococcus pyogenes isolates with high-level macrolide resistance and reduced susceptibility to telithromycin associated with 23S rRNA mutations.

David J Farrell1, Jemma Shackcloth, Karen A Barbadora, Michael D Green.   

Abstract

Seven high-level macrolide-resistant Streptococcus pyogenes isolates had reduced activity to telithromycin but were negative for methylation and efflux genes. All were of the constitutive phenotype, were clonally related (emm type 12 and MLST type 36), and had identical dual mutations (A2058G and U2166C) in domain V of 23S rRNA.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16436755      PMCID： PMC1366915          DOI： 10.1128/AAC.50.2.817-818.2006

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  9 in total

1.  Multilocus sequence typing of Streptococcus pyogenes and the relationships between emm type and clone.

Authors:  M C Enright; B G Spratt; A Kalia; J H Cross; D E Bessen
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

2.  Field inversion gel electrophoresis as a typing system for group A streptococcus.

Authors:  J M Martin; E R Wald; M Green
Journal:  J Infect Dis       Date:  1998-02       Impact factor: 5.226

Review 3.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

4.  In vitro activity of telithromycin against macrolide-susceptible and macrolide-resistant pharyngeal isolates of group A streptococci in the United States.

Authors:  Michael Green; Coburn Allen; John Bradley; Barry Dashefsky; Janet R Gilsdorf; Mario J Marcon; Gordon E Schutze; Clay Smith; Emmanuel Walter; Judith M Martin; Kathryn A Edwards; Karen A Barbadora; Renee M Rumbaugh; Ellen R Wald
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

5.  Molecular characterization of macrolide resistance mechanisms among Streptococcus pneumoniae and Streptococcus pyogenes isolated from the PROTEKT 1999-2000 study.

Authors:  D J Farrell; I Morrissey; S Bakker; D Felmingham
Journal:  J Antimicrob Chemother       Date:  2002-09       Impact factor: 5.790

6.  Streptococcus pneumoniae and Streptococcus pyogenes isolated from a paediatric population in Great Britain and Ireland: the in vitro activity of telithromcycin versus comparators.

Authors:  J Shackcloth; L Williams; D J Farrell
Journal:  J Infect       Date:  2004-04       Impact factor: 6.072

7.  Antimicrobial susceptibility of Streptococcus pneumoniae, Streptococcus pyogenes and Haemophilus influenzae collected from patients across the USA, in 2001-2002, as part of the PROTEKT US study.

Authors:  Steven D Brown; Michael J Rybak
Journal:  J Antimicrob Chemother       Date:  2004-08       Impact factor: 5.790

8.  Macrolide resistance by ribosomal mutation in clinical isolates of Streptococcus pneumoniae from the PROTEKT 1999-2000 study.

Authors:  D J Farrell; S Douthwaite; I Morrissey; S Bakker; J Poehlsgaard; L Jakobsen; D Felmingham
Journal:  Antimicrob Agents Chemother       Date:  2003-06       Impact factor: 5.191

9.  Reemergence of macrolide resistance in pharyngeal isolates of group a streptococci in southwestern Pennsylvania.

Authors:  Michael Green; Judith M Martin; Karen A Barbadora; Bernard Beall; Ellen R Wald
Journal:  Antimicrob Agents Chemother       Date:  2004-02       Impact factor: 5.191
  9 in total
  6 in total

1.  Evolution and global dissemination of macrolide-resistant group A streptococci.

Authors:  D Ashley Robinson; Joyce A Sutcliffe; Wezenet Tewodros; Anand Manoharan; Debra E Bessen
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

2.  Molecular analysis of antimicrobial resistance mechanisms in Neisseria gonorrhoeae isolates from Ontario, Canada.

Authors:  Vanessa G Allen; David J Farrell; Anuradha Rebbapragada; Jingyuan Tan; Nathalie Tijet; Stephen J Perusini; Lynn Towns; Stephen Lo; Donald E Low; Roberto G Melano
Journal:  Antimicrob Agents Chemother       Date:  2010-11-22       Impact factor: 5.191

3.  Phenotypes and genotypes of erythromycin-resistant Streptococcus pyogenes strains isolated from invasive and non-invasive infections from Mexico and the USA during 1999-2010.

Authors:  Alberto Villaseñor-Sierra; Eva Katahira; Abril N Jaramillo-Valdivia; María de los Angeles Barajas-García; Amy Bryant; Rayo Morfín-Otero; Francisco Márquez-Díaz; Juan Carlos Tinoco; José Sánchez-Corona; Dennis L Stevens
Journal:  Int J Infect Dis       Date:  2012-01-02       Impact factor: 3.623

Review 4.  Ketolides--the modern relatives of macrolides : the pharmacokinetic perspective.

Authors:  Markus Zeitlinger; Claudia Christina Wagner; Birgit Heinisch
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

Review 5.  Resistance to Macrolide Antibiotics in Public Health Pathogens.

Authors:  Corey Fyfe; Trudy H Grossman; Kathy Kerstein; Joyce Sutcliffe
Journal:  Cold Spring Harb Perspect Med       Date:  2016-10-03       Impact factor: 6.915

Review 6.  The Expanding Role of Pyridine and Dihydropyridine Scaffolds in Drug Design.

Authors:  Yong Ling; Zhi-You Hao; Dong Liang; Chun-Lei Zhang; Yan-Fei Liu; Yan Wang
Journal:  Drug Des Devel Ther       Date:  2021-10-13       Impact factor: 4.162
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.